Centres by end of year?, page-34

Thank you DV.

The way CardioCel sales are heading I doubt we'll see another CR, perhaps although I think it's doubtful. Especially if the vax platform proves a success and we partner it with a global major. Management of AHZ attract a lot of criticism on this forum (the majority) of which is from people who I suspect i) have no idea what it takes to run a business and ii) don't understand the nature of the world of surgery. I was partly guilty of (ii) when I first invested not appreciating just how conservative that world is, but, despite that conservatism CC is doing so well. As we saw from the figures CC sales for the 1st half of this FY almost matched the sales for the entire previous FY..... some effort! And I predict that sales from this current half will exceed last FY and 1st half of this FY sales combined. This sales performance also gives us proof that the patch and its enabling technology, the ADAPT process are gaining traction in the world of surgery and overcoming that intrinsic conservatism. The snowball has well and truly begun, clinical evidence - revenue - educational seminars - revenue - cliniical evidence - revenue - educational seminars - revenue.....

So exciting.

550+ centres by years end.